$TNDM two questions I’ve been mulling: 1). Could the potential delay in FDA approval be connected to the Medtronic recall back over the summer? FDA has concerns around pumps potentially being vulnerable to hacking. I wonder if the FDA might be taking an extra cautious approach for control-iq? 2) seeing the growth and price action at PODD, I wonder if that at least some of the “pause” referenced could be patients preferring to wait for Horizon closed loop instead. Any informed opinions?